| EPA058 | Rufinamide-induced autophagy cell death in HIV-1-infected macrophages | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA059 | Effect of novel latency reversal agents on transposable element expression profile in T-cell memory subsets of HIV clinical samples | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA060 | Off-target effects on retroelement expression in T-cells Treated with Histone deacetylase inhibitors | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA061 | Nanoparticle delivery of romidepsin to reverse HIV latency | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA063 | Enhanced functional cytotoxic cell populations in PBMCs from individuals with HIV on treatment with ART and dasatinib | E-poster | Immunotherapy (including broadly neutralizing antibodies) |
| EPA064 | Broadly neutralizing HIV-1 antibodies as a PrEP modality among young sexual minority men: a conjoint experiment | E-poster | Immunotherapy (including broadly neutralizing antibodies) |
| EPA065 | Ex vivo HIV suppression in foreskin tissue after oral dosing of F/TDF and F/TAF in young African males | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA066 | Mode of interaction of CD4-CD4i antibody hybrids to HIV-1 envelope glycoproteins | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA067 | Small-molecule CD4-mimetic compounds expose vulnerable HIV-1 Env epitopes and contact the highly conserved aspartic acid 368 | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA068 | Metformin acts on HIV reservoirs to facilitate their recognition by the immune system | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |